|
NZ509978A
(en)
|
1998-09-23 |
2002-12-20 |
Austrian Nordic Biotherapeutic |
Removed particles protected against complement mediated destruction
|
|
WO2001074861A2
(en)
|
2000-03-31 |
2001-10-11 |
Mayo Foundation For Medical Education And Research |
Compositions and methods for tissue specific gene regulation therapy
|
|
CA2464887A1
(en)
|
2001-10-30 |
2003-05-08 |
Biogen, Inc. |
Methods and compositions for treating parkinson's disease
|
|
ES2627445T3
(es)
|
2002-05-01 |
2017-07-28 |
Miltenyi Biotec Technology, Inc. |
Partículas de vector de lentivirus resistentes a la inactivación por el complemento
|
|
US20060045910A1
(en)
|
2004-09-02 |
2006-03-02 |
Ehringer William D |
Preserved fusogenic vesicles
|
|
GB0426641D0
(en)
|
2004-12-03 |
2005-01-05 |
Bioactive Protein Delivery The |
Protein delivery system
|
|
US8034331B2
(en)
|
2005-01-20 |
2011-10-11 |
Agency For Science, Technology And Research |
Method of delivery of nucleic acids to peripheral neurons
|
|
PT1881845E
(pt)
|
2005-04-25 |
2010-05-31 |
Merial Ltd |
Vacinas de vírus nipah
|
|
WO2007005244A1
(en)
|
2005-07-05 |
2007-01-11 |
The Regents Of The University Of California |
Henipavirus receptor and uses thereof
|
|
EP2336181A1
(en)
*
|
2005-12-09 |
2011-06-22 |
UCB Pharma, S.A. |
Antibody molecules having specificity for human IL-6
|
|
EP2062246A4
(en)
|
2006-08-18 |
2010-09-29 |
Univ North Carolina |
VACCINES AGAINST CHIMARICAL VIRUSES
|
|
EP1975239A1
(en)
|
2006-09-27 |
2008-10-01 |
Bundesrepublik Deutschland, letztvertreten durch den Präsidenten des Paul-Ehrlich-Instituts Prof. Dr. Johannes Löwer |
Pseudotyping of retroviral vectors, methods for production and use thereof for targeted gene transfer and high-throughput screening
|
|
WO2008071959A1
(en)
|
2006-12-12 |
2008-06-19 |
Oxford Biomedica (Uk) Limited |
Lentiviral vectors comprising micrornas
|
|
KR20120017469A
(ko)
*
|
2007-01-05 |
2012-02-28 |
유니버시티 오브 취리히 |
질환 특이적 결합 분자 및 표적을 제공하는 방법
|
|
EP4154903A1
(en)
|
2008-04-22 |
2023-03-29 |
Vib Vzw |
Liver-specific nucleic acid regulatory elements and methods and use thereof
|
|
CN102264349A
(zh)
|
2008-11-07 |
2011-11-30 |
儿童医院医疗中心 |
用于跨膜药物递送系统的鞘脂激活蛋白c以及相关蛋白和肽促融合性质
|
|
ES2455544T5
(es)
|
2009-07-24 |
2017-08-16 |
Immune Design Corp |
Vectores de lentivirus pseudotipificados con una glucoproteína de envoltura de virus sindbis
|
|
ES2693167T3
(es)
|
2009-11-13 |
2018-12-07 |
Inserm - Institut National De La Santé Et De La Recherche Médicale |
Administración directa de proteínas con microvesículas modificadas por ingeniería
|
|
EP2476754A1
(en)
|
2011-01-14 |
2012-07-18 |
Bundesrepublik Deutschland, Letztvertreten Durch Den Präsidenten Des Paul-Ehrlich-Instituts |
Methods for the identification and repair of amino acid residues destabilizing single-chain variable fragments (scFv)
|
|
AU2012249474A1
(en)
|
2011-04-28 |
2013-11-07 |
Stc.Unm |
Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same
|
|
GB201121070D0
(en)
|
2011-12-07 |
2012-01-18 |
Isis Innovation |
composition for delivery of biotherapeutics
|
|
EP2615176A1
(en)
|
2012-01-11 |
2013-07-17 |
Paul-Ehrlich-Institut Bundesamt für Sera und Impfstoffe |
Novel pseudotyped lentiviral particles and their use in the in vitro targeted transduction of undifferentiated pluripotent human embryonic stem cells and induced pluripotent stem cells
|
|
WO2013148327A1
(en)
|
2012-03-26 |
2013-10-03 |
The Regents Of The University Of California |
Nipah virus envelope psuedotyped lentiviruses and methods of their use
|
|
ES2686129T3
(es)
|
2012-11-13 |
2018-10-16 |
Codiak Biosciences, Inc. |
Administración de agentes terapéuticos
|
|
CA2904969C
(en)
*
|
2013-03-13 |
2025-06-17 |
Imaginab, Inc. |
DIFFERENTIATION CLUSTER ANTIGEN-BINDING GENETIC CONSTRUCTIONS 8
|
|
GB201313249D0
(en)
|
2013-07-25 |
2013-09-11 |
Isis Innovation |
Method
|
|
EA037503B1
(ru)
|
2014-01-21 |
2021-04-05 |
Анджариум Байосайенсиз Аг |
Способ получения гибридосомы, гибридосома, полученная при помощи способа, и способ доставки терапевтического или диагностического средства
|
|
GB201412494D0
(en)
|
2014-07-14 |
2014-08-27 |
Ospedale San Raffaele And Fond Telethon |
Vector production
|
|
EP4400516A1
(en)
*
|
2014-12-15 |
2024-07-17 |
The Regents of the University of California |
Bispecific or-gate chimeric antigen receptor responsive to cd19 and cd20
|
|
US10501733B2
(en)
|
2015-02-27 |
2019-12-10 |
University Of Washington |
Polypeptide assemblies and methods for the production thereof
|
|
US20180135012A1
(en)
|
2015-05-13 |
2018-05-17 |
Rubius Therapeutics, Inc. |
Membrane-receiver complex therapeutics
|
|
WO2017151717A1
(en)
|
2016-03-01 |
2017-09-08 |
French Brent A |
Compositions and methods for adeno-associated virus mediated gene expression in myofibroblast-like cells
|
|
IL261713B2
(en)
|
2016-03-19 |
2023-09-01 |
F1 Oncology Inc |
Methods and preparations for the transfer of lymphocytes and their regulated expansion
|
|
WO2017173034A1
(en)
|
2016-03-30 |
2017-10-05 |
The University Of North Carolina At Chapel Hill |
Biological agent-exosome compositions and uses thereof
|
|
EP3235908A1
(en)
*
|
2016-04-21 |
2017-10-25 |
Ecole Normale Superieure De Lyon |
Methods for selectively modulating the activity of distinct subtypes of cells
|
|
JP7072807B2
(ja)
|
2016-06-09 |
2022-05-23 |
アルマ・マテール・ストゥディオルム・ウニベルシータ・ディ・ボローニャ |
細胞内増殖のための改変糖タンパク質ｈを有するヘルペスウイルス
|
|
EP3472318B1
(en)
|
2016-07-08 |
2023-09-06 |
Exuma Biotech Corp. |
Methods and compositions for transducing lymphocytes and regulating the activity thereof
|
|
KR20190053179A
(ko)
|
2016-07-26 |
2019-05-17 |
센티 바이오사이언시스, 인코포레이티드 |
유전자 지우개들
|
|
EP3346001A1
(en)
*
|
2017-01-06 |
2018-07-11 |
TXCell |
Monospecific regulatory t cell population with cytotoxicity for b cells
|
|
AU2018206485B2
(en)
|
2017-01-09 |
2024-12-05 |
Oisin Biotechnologies |
Fusogenic lipid nanoparticles and methods for manufacturing and use for therapeutic protein production and for treatment
|
|
AU2018266111B2
(en)
|
2017-05-08 |
2024-11-07 |
Flagship Pioneering Innovations V, Inc. |
Compositions for facilitating membrane fusion and uses thereof
|
|
KR102880156B1
(ko)
*
|
2017-07-24 |
2025-11-05 |
리제너론 파마슈티칼스 인코포레이티드 |
항cd8 항체 및 이의 용도
|
|
US20210187018A1
(en)
|
2017-12-07 |
2021-06-24 |
Flagship Pioneering Innovations V, Inc. |
Cytobiologics and therapeutic uses thereof
|
|
AU2019215063B2
(en)
|
2018-02-01 |
2025-10-16 |
Bioverativ Therapeutics, Inc. |
Use of lentiviral vectors expressing Factor VIII
|
|
CA3091478A1
(en)
|
2018-02-17 |
2019-08-22 |
Flagship Pioneering Innovations V, Inc. |
Compositions and methods for membrane protein delivery
|
|
CA3100050A1
(en)
*
|
2018-05-11 |
2019-11-14 |
Lupagen, Inc. |
Systems and methods for closed loop, real-time modifications of patient cells
|
|
AU2019269593A1
(en)
|
2018-05-15 |
2020-11-26 |
Flagship Pioneering Innovations V, Inc. |
Fusosome compositions and uses thereof
|
|
EP3820509A1
(en)
|
2018-07-09 |
2021-05-19 |
Flagship Pioneering Innovations V, Inc. |
Fusosome compositions and uses thereof
|
|
EA202191176A1
(ru)
*
|
2018-10-31 |
2021-07-28 |
Делиниа, Инк. |
Поливалентные модуляторы регуляторных т-клеток
|
|
US12496274B2
(en)
|
2018-11-14 |
2025-12-16 |
Flagship Pioneering Innovations V, Inc. |
Compositions and methods for compartment-specific cargo delivery
|
|
EP3880832A1
(en)
|
2018-11-14 |
2021-09-22 |
Flagship Pioneering Innovations V, Inc. |
Fusosome compositions for hematopoietic stem cell delivery
|
|
WO2020102503A2
(en)
|
2018-11-14 |
2020-05-22 |
Flagship Pioneering Innovations V, Inc. |
Fusosome compositions for t cell delivery
|
|
SG11202105079QA
(en)
|
2018-11-14 |
2021-06-29 |
Flagship Pioneering Innovations V Inc |
Fusosome compositions for cns delivery
|
|
AU2020341454A1
(en)
*
|
2019-09-03 |
2022-03-10 |
Sana Biotechnology, Inc. |
CD24-associated particles and related methods and uses thereof
|
|
JP2023521663A
(ja)
*
|
2020-03-31 |
2023-05-25 |
サナ バイオテクノロジー，インコーポレイテッド |
標的化脂質粒子及び組成物ならびにその使用
|
|
EP4274901A1
(en)
*
|
2021-01-11 |
2023-11-15 |
Sana Biotechnology, Inc. |
Use of cd8-targeted viral vectors
|
|
IL307544A
(en)
*
|
2021-04-08 |
2023-12-01 |
Sana Biotechnology Inc |
Cd8-specific antibody constructs and compositions thereof
|